Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Pyxis Oncology, Inc. (PYXS) had Return on Equity of -149.08% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$13.86M |
|
$-79.62M |
|
$2.39M |
|
$11.47M |
|
$98.28M |
|
$-84.42M |
|
$6.18M |
|
$-78.23M |
|
$-78.23M |
|
$-79.62M |
|
$-79.62M |
|
$-79.62M |
|
$-79.62M |
|
$-84.42M |
|
$-82.87M |
|
62.14M |
|
62.14M |
|
$-1.28 |
|
$-1.28 |
|
| Balance Sheet Financials | |
$72.11M |
|
$8.00M |
|
$19.41M |
|
$91.52M |
|
$21.13M |
|
-- |
|
$16.98M |
|
$38.11M |
|
$53.41M |
|
$53.41M |
|
$53.41M |
|
62.69M |
|
| Cash Flow Statement Financials | |
$-63.50M |
|
$58.86M |
|
$0.59M |
|
$20.95M |
|
$16.89M |
|
$-4.05M |
|
$11.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
82.77% |
|
-609.18% |
|
-609.18% |
|
-597.99% |
|
-564.55% |
|
-574.55% |
|
$-63.51M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-149.08% |
-149.08% |
|
-87.00% |
|
-149.08% |
|
$0.85 |
|
$-1.02 |
|
$-1.02 |
|